Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions AED. Fiscal year is January - December.

Millions AED. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	79,605	72,138	74,242	76,046	-
Market Cap Growth	8.96%	-2.83%	-2.37%	-	-
Enterprise Value	89,577	83,661	85,956	87,476	-
Last Close Price	2.66	2.33	2.25	2.17	-
PE Ratio	19.40	16.03	20.39	19.06	-
Forward PE	19.01	16.84	16.81	15.04	-
PS Ratio	3.65	3.26	3.49	3.45	-
PB Ratio	5.14	4.38	4.45	4.25	-
P/TBV Ratio	5.25	4.46	4.52	4.32	-
P/FCF Ratio	12.96	11.20	12.82	11.49	-
P/OCF Ratio	11.08	10.27	11.43	10.50	-
EV/Sales Ratio	4.10	3.78	4.04	3.97	-
EV/EBITDA Ratio	10.65	9.26	10.85	11.25	-
EV/EBIT Ratio	13.95	11.84	14.64	14.29	-
EV/FCF Ratio	14.59	12.99	14.84	13.22	-
Debt / Equity Ratio	0.74	0.70	0.73	0.85	-
Debt / EBITDA Ratio	1.36	1.26	1.54	1.95	-
Debt / FCF Ratio	1.87	1.78	2.11	2.30	-
Asset Turnover	0.69	0.68	0.60	-	-
Inventory Turnover	5.77	5.48	5.63	-	-
Quick Ratio	1.42	1.62	1.49	2.21	-
Current Ratio	2.09	2.32	2.24	2.86	-
Return on Equity (ROE)	26.06%	27.45%	21.26%	-	-
Return on Assets (ROA)	12.65%	13.63%	10.42%	-	-
Return on Capital (ROIC)	14.64%	15.55%	11.83%	-	-
Return on Capital Employed (ROCE)	23.30%	24.80%	19.90%	18.10%	-
Earnings Yield	5.17%	6.24%	4.90%	5.25%	-
FCF Yield	7.72%	8.93%	7.80%	8.70%	-
Dividend Yield	5.97%	6.82%	7.03%	-	-
Payout Ratio	115.97%	106.08%	131.13%	44.86%	-
Total Shareholder Return	6.11%	6.82%	7.03%	-	-

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.